Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: A prospective study

Stroke

Volumn 39, Issue 5, 2008, Pages 1487-1490

  Stam, Jan ^a,b   Majoie, Charles B L M ^b   Van Delden, Otto M ^b   Van Lienden, Krijn P ^b   Reekers, Jim A ^b  

^a Departments of Neurology   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Intracranial; Sinus thrombosis; Thrombolytic therapy

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; UROKINASE; FIBRINOLYTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN HERNIA; BRAIN INFARCTION; CEREBRAL SINUS THROMBOSIS; CHILD; CLINICAL ARTICLE; COMA; CONTROLLED STUDY; DETERIORATION; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EPILEPTIC STATE; FEMALE; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; LEUKEMIA; MALE; MORTALITY; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RANKIN SCALE; SCHOOL CHILD; SURVIVAL; SURVIVOR; TONIC CLONIC SEIZURE; CLINICAL TRIAL; COMPARATIVE STUDY; CRANIAL SINUS; DRUG EFFECT; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICS; TREATMENT OUTCOME; VASCULAR SURGERY;

ADULT; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; CRANIAL SINUSES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR; VASCULAR SURGICAL PROCEDURES;

EID: 44449086511     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.502658     Document Type: Article

References (19)

1. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.
2. De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-488.
3. Nagaraja D, Haridas T, Taly AB, Veerendrakumar M, SubbuKrishna DK. Puerperal cerebral venous thrombosis: therapeutic benefit of low dose heparin. Neurol India. 1999;47:43-46.
4. Stam J, de Bruijn S, deVeber G. Anticoagulation for cerebral sinus thrombosis. Stroke. 2003;34:1054-1055.
5. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-670.
6. Baker MD, Opatowsky MJ, Wilson JA, Glazier SS, Morris PP. Rheolytic catheter and thrombolysis of dural venous sinus thrombosis: a case series. Neurosurgery. 2001;48:487-493.
7. Tsai FY, Wang AM, Matovich VB, Lavin M, Berberian B, Simonson TM, Yuh WT. MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol. 1995;16:1021-1029.
8. Horowitz M, Purdy P, Unwin H, Carstens G, III, Greenlee R, Hise J, Kopitnik T, Batjer H, Rollins N, Samson D. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol. 1995;38:58-67.
9. Kim SY, Suh JH. Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase. AJNR Am J Neuroradiol. 1997; 18:639-645.
10. Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke. 1999;30:489-494.
11. Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N, Unwin DH. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke. 2001;32:2310-2317.
12. Soleau SW, Schmidt R, Stevens S, Osborn A, MacDonald JD. Extensive experience with dural sinus thrombosis. Neurosurgery. 2003;52: 534-544.
13. Canhao P, Falcao F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis. 2003;15:159-166.
14. Canhao P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarre-menteria F. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720-1725.
15. deVeber G, Andrew M. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423.
16. Wermes C, Fleischhack G, Junker R, Schobess R, Schwabe D, Sykora KW, Nowak-Gottl U. Cerebral venous sinus thrombosis in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype and further prothrombotic risk factors. Klin Padiatr. 1999;211:211-214.
17. Stefini R, Latronico N, Cornali C, Rasulo F, Bollati A. Emergent decom-pressive craniectomy in patients with fixed dilated pupils due to cerebral venous and dural sinus thrombosis: report of three cases. Neurosurgery. 1999;45:626-629.
18. Keller E, Pangalu A, Fandino J, Konu D, Yonekawa Y. Decompressive craniectomy in severe cerebral venous and dural sinus thrombosis. Acta Neurochir Suppl. 2005;94:177-183.
19. Ferro JM, Rodrigues T, Bacelor Nicolau L, Canhao P, Crassard I, Bousser M-G, et al. Development of a risk score to predict the prognosis of cerebral vein and dural sinus thrombosis (CVT). Cerebrovasc Dis. 2007; 23(Suppl 2):141.